Q4 2019 Aytu BioScience Inc Earnings Call
Conference Call Aytu BioScience Inc
Aytu BioScience Inc Conference call or earnings call will be held on Sep 26, 2019 via an 800 number (toll-free). During the earnings conference call's session Aytu BioScience Inc will provide updated information and financial status.
Conference call is also referred to as: teleconference call or audio conference bridge. Conferencing service is provided in house or as cloud based teleconference service.
In order to join the audio conferencing dial conference bridge and key in the PIN code, Contact Aytu BioScience Inc for this information
Schedule a teleconference with QCONF and get 5 free calls with our conference service.
We are a commercial-stage specialty healthcare company focused on acquiring, developing and commercializing novel products in the field of urology. We have multiple urology-focused products on the market, and we seek to build a portfolio of novel therapeutics that serve large medical needs in the field of urology. We are concentrating on hypogonadism, prostate cancer, male infertility and, recently, female sexual wellbeing and intimacy and plan to expand into other urological indications for which we believe there are significant medical needs. We acquired exclusive U.S. rights to Natesto® (testosterone) nasal gel, a novel formulation of testosterone delivered via a discreet, easy-to-use nasal gel, and we launched Natesto in the United States with our direct sales force in late summer 2016. Natesto is approved by the U.S.Read more Conference Call